Sedana Medical AB (publ) (FRA:7D2A)

Market Cap	88.84M -44.1%
Revenue (ttm)	18.50M +12.0%
Net Income	-5.47M
EPS	-0.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.8680
Previous Close	0.8870
Day's Range	0.8680 - 0.8680
52-Week Range	0.5790 - 1.6300
Beta	n/a
RSI	45.98
Earnings Date	Feb 12, 2026

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the adminis...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1999
• Employees: 122
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7D2A

Financial Performance

In 2025, Sedana Medical AB's revenue was 200.23 million, an increase of 12.01% compared to the previous year's 178.75 million. Losses were -59.24 million, 455.0% more than in 2024.

Financial numbers in SEK